parkinson glutathione oxidative ipsc crispr Using induced pluripotent stem cells for modeling Parkinson's disease CRISPR-Cas9-Based Technology and Its Relevance
CRISPR Cas9 Based Technology and Its Relevance to Gene Editing in Parkinson's Disease PMC Interrogating Parkinson's disease associated redox targets: Potential application of CRISPR editing ScienceDirect CRISPR And iPSC Disease Modeling And Drug Screening Stem cells strike back: advancements in Alzheimer's and Parkinson's disease treatment and modeling efforts from 2019 to 2024 PMC iPSC derived dopaminergic neurons from syndromic OPA1 parkinsonism Download Scientific Diagram Past, present, and future of cell replacement therapy for parkinson's disease: a novel emphasis on host immune responses Cell Research
Pay in 4 interest-free payments of $6.72 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8





